1. Amidon GL, Lennernas VP, Crison JR. A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12:413-420.
2. Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res 2004; (21)2:210-230.
3. Shah NH, Carvajal MT, Patel CI, Infeld MH, Malick AW. Self emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving invitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994; 106:15-23.
4. Wasan KM. Formulation and physiologic and biopharmaceutical issues in the development of oral lipid based drug delivery systems. Drug Dev Ind Pharm 2001; 27(4):267-276.
5. Yeh PY. Effect of medium chain glycerides on physiological properties of rabbit intestinal epithelium in vitro. Pharm Res 1994; 11(8):1148-1154.
6. Caliph SM, Charman WN, Porter CJH. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halo tantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci 2000; 89(8):1073-1084.
7. Hauss DJ, Fogal SE, Ficorilli JV, et al. Lipid based delivery systems for improving the bioavailability and lymphatic transport of a poorly water soluble LTB4 inhibitor. J Pharm Sci 1998; 87(2):164-169.
8. Charman WNA, Stella VJ. Transport of lipophilic molecules by the intestinal lymphatic system. Adv Drug Del Rev 1991; 7:1-14.
9. Welling PG. Influence of food and diet on gastrointestinal drug absorption: a review. J Pharmacokinet Biopharm 1977; 5:292-334.
10. Shah NH, Phuapradit W, Ahmed H. Liquid/semi solid filling in hard gelatin capsules: formulation and processing considerations. Semi-solid formulations and oral absorption enhancement. Bulletin Technique Gattefosse 1996; 27-37.
11. Stegemann S. Liquid and semisolid formulation in hard gelatin capsules. Swiss Pharma 1999; 21(6):21-28.
12. Microemulsions Formulation Guide. Gattefosse technical document MEP 3-18. Pharmaceutical Department Edition, May 1992.
13. Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst 1999; 16:461-521.
Charman WN, Porter CJH, Mithani S, Dressman JB. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997; 86(3):269-282.
Serajuddin ATM, Sheen PC, Augustine MA. Water migration from soft gelatin capsule shell to filled material and its effect on drug solubility. J Pharm Sci 1986; 75(1):62-64. Cade D, Madit N. Liquid filling in hard gelatin capsules-preliminary steps. Lecture presented at Gattefosse Symposium, June 1966. Capsugel Library, BAS 1998:191. Craig QM. The physical characterization of Gelucire 50/13. Semi solid formulations and oral absorption enhancement. Bulletin Technique Gattefosse 1996. Duddu SP, Roussin P, Laforet JP, Pad NR. A Gelucire 50/13 theophylline formulation. Semi solid formulations and oral absorption enhancement. Bulletin Technique Gattefosse 1996.
Sutananta W, Craig DQM, Newton JM. An investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glyceride bases. J Pharm Pharmacol 1995; 47:355-359.
Gelucine® solid product literature. Controlled Release and Increased Bioavailability. PF 96327 page 12, 1st edition, April 1999.
Gattefosse internal communication. Controlled Release and Increased Bioavailability. PF 96327 page 12, 1st edition, April 1999.
Bowtle WJ. Liquid filling of hard gelatin capsules: a new technology for alternative formulations. Pharm Tech Eur 1998; 10:84-90.
Khalil SA, Ali MM, Khalek AMMA. Effects of aging and relative humidity on drug release. Part 1. Chloramphenicol capsules. Pharmazie 1974; 29:36-37.
Cade D, Madit N, Cole ET. Development of a test procedure to consistently ross-link hard gelatin capsules with formaldehyde. Pharm Res (New York) 1994; 11(suppl
Hartauer KJ, Bucko JH, Cooke GG, Mayer RF, Schwier JR, Sullivan GR. The effect of rayon coiler on the dissolution stability of hard-shell gelatin capsules. Pharm Tech 1993; 17:76-83.
Chen GL, Hao WH. Factors affecting zero-order release kinetics of porous gelatin capsules. Drug Dev Ind Pharm 1998; 24(6):557-562.
Cade D, Madit N. Liquid filling of hard gelatin—preliminary steps. Capsugel Library Publication 1998.
Internal communication with Shionogi Qualicaps. Unpublished internal data.
Unpublished internal data generated using Shionogi test method to assess capsule brittleness.
Serajuddin ATM, Sheen PC, Augustine MA. Water migration from soft gelatin capsule shell to filled material and its effect on drug solubility. J Pharm Sci 1986; 75:62-64.
Stanley JP. Soft gelatin capsules. In: Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia: Lea and Febiger, 1986:398-412.
Arthur HK. Handbook of Pharmaceutical Excipients. 3rd ed. Washington, DC: AphA, 2000.
Fresh PaxTM oxygen absorbing packet. Multisorb Technologies Inc., Buffalo, New York, U.S.A., 14224-1893.
35. Ebert WR. Soft elastic gelatin capsules: a unique dosage form, Pharm Technol 1977; 1:44-50.
36. AAPS Workshop Committee. Scale-up of liquid and semisolid disperse systems. Pharm Technol 1995; 19(6):52-60.
37. Shah NH, Phuapradit W, Ahmed H. Liquid/semi solid filling in hard gelatin capsules: formulation and processing considerations. Semi-solid formulations and oral absorption enhancement. Bulletin Technique Gattefosse 1996; 27-37.
38. Cole ET. Liquid filled hard gelatin capsules. Pharm Tech 1989; 13(9):124-140.
Was this article helpful?
If you suffer with asthma, you will no doubt be familiar with the uncomfortable sensations as your bronchial tubes begin to narrow and your muscles around them start to tighten. A sticky mucus known as phlegm begins to produce and increase within your bronchial tubes and you begin to wheeze, cough and struggle to breathe.